Perspective Therapeutics, Inc.

AMEX:CATX

Medical - Devices

Healthcare
$0.78 +0.50%

+$0.02 today

Market cap
$94.20M
Beta
1.73
P/E (TTM)
-0.0
EPS (TTM)
-$107.27
52W Low $1.96High $6.16

Volume 2.69M

Average 1.44M

CATX Other Stockholders Equity

Equity items not reported separately, such as additional paid-in capital or treasury stock.

Perspective Therapeutics, Inc.AMEX: CATX

Other Stockholders Equity · Q1 FY2026 · quarter ended Mar 2026

Other stockholders equity remains negative

Q1 FY2026 other stockholders equity was $0, compared with $0 a year earlier.

Context

  • Other stockholders equity amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Other stockholders equity increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Other Stockholders Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Stockholders Equity history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Other Stockholders Equity vs competitors

How CATX compares with its peers on the latest reported figures

  • CATX's Mar 2026 other stockholders equity of $0 is the highest of the 5 companies compared; the peer median is $0.
  • Other stockholders equity amounts to 0.0% of total assets for CATX, versus a peer median of 0.0%.
CATX Competitors Peer median
Other Stockholders Equity for CATX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CATXPerspective Therapeutics, Inc.Mar 2026$0 ——0.0%
NVCRNovoCure LimitedMar 2026$0 ——0.0%
DCTHDelcath Systems, Inc.Mar 2026$0 ——0.0%
TLSITriSalus Life Sciences, Inc.Mar 2026$0 ——0.0%
SRTSSensus Healthcare, Inc.Mar 2026$0 ——0.0%
Peer median (excluding CATX) $0——0.0%

Competitors are the stored peer set for CATX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Jun 2022
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents60.35M20.99M9.24M61.58M30.63M
Short-term Investments022.76M0165.34M114.11M
Net Receivables1.65M1.36M1.18M116K6K
Inventory1.07M1.41M000
Other Current Assets535K6.69M5.35M4.13M3.65M
Total Current Assets63.6M53.22M16.84M231.16M148.39M
Property, Plant & Equipment (Net)2.62M2.06M6.32M59.54M78.1M
Goodwill0024.06M00
Intangible Assets107K86K50.35M50M40M
Long-term Investments0150K133K00
Tax Assets00000
Other Non-current Assets926K(2.3M)182K405K486K
Total Non-current Assets3.65M2.3M81.05M109.94M118.58M
Total Assets67.25M58.09M97.89M341.1M266.97M
Account Payables847K1.54M6.91M10.34M20.51M
Short-term Debt0049K52K623K
Tax Payables00000
Deferred Revenue0001.4M26.6M
Other Current Liabilities259K(406K)4.73M5.48M1.46M
Total Current Liabilities1.85M2.68M15.66M18.23M28.68M
Long-term Debt001.68M1.63M1.01M
Deferred Tax Liabilities004.59M2.5M1.7M
Deferred Revenue (Non-current)00026.6M0
Other Non-current Liabilities624K75K4.59M55K28.56M
Total Non-current Liabilities1.02M331K7.05M32.2M31.26M
Total Liabilities2.86M3.45M22.71M50.43M59.94M
Common Stock142K142K282K70K74K
Retained Earnings(95.17M)(105.93M)(152.44M)(231.72M)(334.84M)
Accumulated OCI000(51K)110K
Other Stockholders Equity0160.43M000
Minority Interest00000
Total Equity64.39M54.64M75.18M290.67M207.03M
Total Debt652K524K2.55M4.06M1.63M
Net Debt(59.7M)(20.99M)(6.69M)(57.52M)(29M)

Perspective Therapeutics, Inc.

AMEX:CATX

Intrinsic Alpha fair value

Locked

Current Price

$0.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.